Table 2

Inhibitory effects of several endogenous compounds and xenobiotics on carnitine uptake by OCTN2-expressing HEK 293 cells

InhibitorConcentrationRelative Uptake
μM % of Control
Control100
Endogenous Compounds
l-Carnitine583.1  ± 1.142-150
 Guanidine50091.3  ± 4.49
N 1-methylnicoti namide50099.3  ± 2.94
 Choline50074.6  ± 4.592-150
 Acetylcholine50079.1  ± 1.222-150
 Acetylcholine500034.2  ± 0.332-150
 Serotonin50081.4  ± 4.79
 Serotonin500051.3  ± 0.462-150
 Dopamine50081.3  ± 0.852-150
 Dopamine500070.9  ± 0.462-150
 Epinephrine500105.9  ± 2.11
 Epinephrine5000106.1  ± 2.65
 Norepinephrine50093.9  ± 5.77
 Norepinephrine500070.9  ± 0.462-150
 Histamine5000100.0  ± 3.26
 Thiamine50077.4  ± 2.252-150
 Thiamine500065.9  ± 0.582-150
 α-Ketoglutarate50096.4  ± 1.58
 PAH500100.4  ± 1.23
Xenobiotics
 TEA5067.8  ± 0.372-150
 TEA50015.4  ± 0.732-150
 MPP50072.9  ± 1.792-150
 Acetyl-ß-methylcho line50082.5  ± 1.542-150
 Pyrilamine50036.3  ± 0.632-150
 Diphenhydramine50043.6  ± 1.742-150
 Procainamide50081.3  ± 1.872-150
 Lidocaine50057.1  ± 1.142-150
 Quinidine5006.1  ± 0.402-150
 Verapamil5001.3  ± 0.122-150

The uptake of [3H]carnitine was measured for 3 min at 37°C in Na+-containing transport buffer, pH 7.4, containing each compound. Each value represents the mean ± S.E.M. of three determinations. The data represent the difference in uptakes by Mock and OCTN2-expressing HEK293 cells.

    • 2-150  Significantly different from the control uptake by Student's t test (p < 0.05).